Study: Men, Women Respond Differently To Smoking-Cessation Medication.

The Toronto (CAN) Star (12/12, Hall) reports on a study published in the December issue of the journal Biological Psychiatry that examines the differences in how a tobacco-cessation medication, naltrexone, affects men and women. According to the article, “the study of 700 smokers — all of them using tobacco patches — showed those men using” the medication “increased their chances of quitting from 17 to 30 per cent after a 12-week trial.” However, for women, “the increase in quit rates were negligible.”

Related Links:

— “Anti-smoking drug Naltrexone has his and hers effects, “Joseph Hall, The Toronto Star, December 11, 2012.

Posted in In The News.